News [Publication Type]
LEO Pharma Acquires Exclusive Global Rights for Boehringer Ingelheim’s Psoriasis Drug Spevigo in €90 Million Deal
LEO Pharma; Boehringer Ingelheim; Spevigo; spesolimab; psoriasis; GPP; drug licensing; immunology; IL-36 receptor; partnership; biotech news
Sernova Chair Resigns After Insider Trading Indictment Tied to Novartis-Chinook Deal
Sernova Biotherapeutics; insider trading; resignation; Ross Haghighat; Novartis-Chinook acquisition; securities fraud; biotech news; DOJ indictment
Incyte’s $750M Acquisition Hits Roadblock: Key Trial Paused and Asset Cull Announced
Incyte, $750M buyout, paused trial, asset cull, biotech news, pharmaceutical industry
Takeda Terminates Partnership with Wave Life Sciences on Huntington’s Disease Program
Takeda, Wave Life Sciences, Huntington’s disease, WVE-003, partnership termination, biotech news
Pfizer Generates $2.88 Billion by Selling Off Hundreds of Millions of Haleon Shares
Pfizer, Haleon, share sale, pharmaceutical industry, financial news
Roche Secures FDA Approval for Subcutaneous Ocrevus and Tecentriq, Lilly Gains Approval for Eczema Treatment
FDA approvals, Roche, Subcutaneous products, Ocrevus, Tecentriq, Lilly, Eczema treatment, Pharmaceutical industry, Biopharma news